Related Experiment Video
Updated: Jan 6, 2026

Author Spotlight: Understanding the Effect of Herbal-Cake-Separated Moxibustion in Rats with Renal Faliure
Published on: December 22, 2023
Burning Feet, Dilated Heart and Failed Kidneys.
S P Yadav1, A Abraham2, R Nadig3
1Department of Pediatric Nephrology, St. John's Medical College Hospital, Bengaluru, Karnataka, India.
Fabry disease, a genetic disorder, can cause early kidney failure. This case highlights a 16-year-old diagnosed with end-stage renal disease due to low alpha-galactosidase A activity.
Area of Science:
- Genetics
- Nephrology
- Biochemistry
Background:
- Fabry disease is an X-linked lysosomal storage disorder caused by alpha-galactosidase A (α-GalA) deficiency.
- Renal involvement typically manifests in the third decade of life.
Observation:
- A 16-year-old male presented with end-stage renal disease (ESRD).
- Kidney biopsy revealed characteristic myeloid bodies on electron microscopy.
Findings:
- Diagnosis of Fabry disease was confirmed by low serum α-GalA levels.
- The patient exhibited an unusually early onset of renal disease.
Implications:
- This case underscores the importance of considering Fabry disease in young patients with unexplained ESRD.
- Early diagnosis and management are crucial for mitigating severe complications of Fabry disease.
More Related Videos
08:505/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
10:31Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
Published on: May 2, 2025
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Heart Failure III: Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Heart Failure I: Introduction
Heart Failure Drugs: Diuretics
Heart Failure II: Pathophysiology